NCT05027516View on ClinicalTrials.gov

Trial Comparing Ceftriaxone Plus Azithromycin Versus Ceftriaxone for the Treatment of Gonorrhea

PHASE4CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 17, 2022

Primary Completion Date

May 9, 2022

Study Completion Date

May 9, 2022

Conditions
Neisseria Gonorrhoeae
Interventions
DRUG

Rocephin

Single dose of Rocephine® (= ceftriaxone 1g + lidocaine 35mg) intramuscular injection

DRUG

Azithromycin

Single dose of Rocephine® (= ceftriaxone 1g + lidocaine 35mg) intramuscular injection + single dose of azithromycin 2g orally

Trial Locations (1)

2000

Institute of Tropical Medicine, Antwerp

All Listed Sponsors
lead

Institute of Tropical Medicine, Belgium

OTHER